Comments on: Novartis’ Zolgensma experiences further safety issues /news/novartis-zolgensma-safety-issues/ The leading site for news and procurement in the pharmaceutical industry Thu, 24 Mar 2022 11:20:11 +0000 hourly 1 https://wordpress.org/?v=6.6.1